Bodal Chemicals Ltd
Bodal Chemicals Limited is one of India’s leading integrated Dyestuff companies and is the largest domestic manufacturer of Dye Intermediates. It offers a wide range of Dyestuffs, Dye Intermediates, Basic Chemicals, and its variants to diverse customers across India and the world. [1]
- Market Cap ₹ 687 Cr.
- Current Price ₹ 54.5
- High / Low ₹ 81.5 / 49.6
- Stock P/E 20.6
- Book Value ₹ 92.6
- Dividend Yield 0.00 %
- ROCE 5.26 %
- ROE 1.78 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 0.60 times its book value
- Company's working capital requirements have reduced from 23.8 days to 15.8 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.09% over past five years.
- Company has a low return on equity of 1.54% over last 3 years.
- Dividend payout has been low at 1.35% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Dyes And Pigments
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 960 | 1,043 | 907 | 1,182 | 1,121 | 1,379 | 1,224 | 1,130 | 2,011 | 1,555 | 1,386 | 1,723 | 1,797 | |
| 770 | 859 | 758 | 961 | 924 | 1,146 | 1,091 | 1,047 | 1,787 | 1,434 | 1,279 | 1,557 | 1,628 | |
| Operating Profit | 189 | 184 | 150 | 221 | 197 | 233 | 133 | 83 | 224 | 121 | 108 | 166 | 169 |
| OPM % | 20% | 18% | 17% | 19% | 18% | 17% | 11% | 7% | 11% | 8% | 8% | 10% | 9% |
| -70 | 5 | 20 | 15 | 12 | 15 | 14 | 18 | 8 | 8 | 15 | 8 | 24 | |
| Interest | 47 | 27 | 12 | 7 | 5 | 7 | 14 | 9 | 21 | 34 | 52 | 80 | 82 |
| Depreciation | 25 | 22 | 26 | 26 | 11 | 18 | 26 | 28 | 46 | 52 | 60 | 68 | 68 |
| Profit before tax | 47 | 139 | 132 | 203 | 193 | 222 | 106 | 64 | 165 | 43 | 12 | 27 | 44 |
| Tax % | 35% | 34% | 34% | 35% | 34% | 35% | 15% | 24% | 25% | 27% | 35% | 26% | |
| 31 | 92 | 87 | 133 | 128 | 144 | 90 | 48 | 124 | 31 | 8 | 20 | 32 | |
| EPS in Rs | 2.81 | 8.43 | 7.94 | 12.18 | 10.44 | 11.79 | 7.37 | 3.95 | 10.15 | 2.48 | 0.61 | 1.55 | 2.57 |
| Dividend Payout % | 0% | 0% | 8% | 7% | 8% | 7% | 11% | 20% | 8% | 4% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 7% |
| 3 Years: | -5% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | -26% |
| 3 Years: | -45% |
| TTM: | 353% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -6% |
| 3 Years: | -12% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 4% |
| 3 Years: | 2% |
| Last Year: | 2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 |
| Reserves | 47 | 139 | 218 | 341 | 678 | 811 | 912 | 968 | 1,078 | 1,101 | 1,108 | 1,127 | 1,141 |
| 397 | 234 | 143 | 142 | 148 | 135 | 238 | 436 | 640 | 755 | 903 | 911 | 866 | |
| 132 | 145 | 132 | 187 | 191 | 265 | 249 | 279 | 384 | 281 | 300 | 333 | 319 | |
| Total Liabilities | 597 | 539 | 514 | 692 | 1,041 | 1,235 | 1,424 | 1,708 | 2,127 | 2,163 | 2,336 | 2,396 | 2,351 |
| 168 | 190 | 184 | 196 | 412 | 529 | 613 | 760 | 804 | 955 | 1,302 | 1,291 | 1,268 | |
| CWIP | 8 | 3 | 0 | 9 | 14 | 20 | 1 | 4 | 70 | 193 | 68 | 61 | 61 |
| Investments | 2 | 3 | 3 | 21 | 24 | 20 | 41 | 44 | 99 | 100 | 113 | 101 | 101 |
| 419 | 343 | 326 | 465 | 591 | 666 | 770 | 899 | 1,155 | 914 | 852 | 943 | 920 | |
| Total Assets | 597 | 539 | 514 | 692 | 1,041 | 1,235 | 1,424 | 1,708 | 2,127 | 2,163 | 2,336 | 2,396 | 2,351 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49 | 198 | 133 | 112 | 22 | 210 | 65 | -22 | 30 | 246 | 191 | 106 | |
| -21 | -35 | -24 | -100 | -216 | -175 | -146 | -171 | -194 | -315 | -266 | -39 | |
| -27 | -162 | -109 | -9 | 191 | -29 | 86 | 186 | 162 | 69 | 88 | -71 | |
| Net Cash Flow | 1 | 0 | -1 | 3 | -3 | 6 | 6 | -6 | -2 | 1 | 14 | -5 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 69 | 67 | 56 | 89 | 77 | 111 | 128 | 98 | 95 | 99 | 84 |
| Inventory Days | 72 | 43 | 56 | 57 | 58 | 77 | 90 | 126 | 141 | 112 | 128 | 134 |
| Days Payable | 66 | 62 | 67 | 75 | 77 | 80 | 92 | 101 | 83 | 76 | 101 | 98 |
| Cash Conversion Cycle | 92 | 50 | 56 | 39 | 70 | 74 | 109 | 152 | 155 | 131 | 126 | 120 |
| Working Capital Days | 41 | 23 | 17 | 18 | 65 | 45 | 46 | 51 | 51 | 43 | 12 | 16 |
| ROCE % | 39% | 39% | 35% | 46% | 29% | 25% | 11% | 6% | 11% | 4% | 3% | 5% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Bodal Chemicals Limited herewith submit copies of Newspaper publications
-
Announcement under Regulation 30 (LODR)-Investor Presentation
12 Nov - Bodal Chemicals Limited herewith submit Investor Presentation
-
Board Meeting Outcome for Outcome Of Board Meeting
12 Nov - Approved Q2/H1 FY26 results; sold Vatva units, gains Rs106.60m and Rs72.34m; H1 PBT Rs180.72m.
- Results - Financial Results For Quarter And Half Year Ended 30 September 2025 12 Nov
-
Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results And Any Other Business With Permission Of The Chairman
5 Nov - Board meeting 12 Nov 2025 to approve results for quarter/half-year ended 30 Sep 2025; trading window reopens 15 Nov.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020TranscriptNotesPPT
-
Nov 2020Transcript PPT
-
Sep 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Mar 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
Jun 2019TranscriptPPT
-
May 2019Transcript PPT
-
May 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Mar 2019TranscriptNotesPPT
-
Mar 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Oct 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018Transcript PPT
-
Jun 2018Transcript PPT
-
May 2018TranscriptNotesPPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Dec 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Mar 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Nov 2016Transcript PPT
-
Aug 2016TranscriptNotesPPT
-
Jun 2016TranscriptNotesPPT
-
Feb 2016TranscriptNotesPPT
Product Portfolio (200+ products)[1]
Basic Chemicals (12 products)
Dye Intermediates (25 products)
Dyestuffs (175 products)
Chlor Alkali (6 products)
New Product Addition: Benzene Derivatives (5 products)